Patents by Inventor Robert Pordy

Robert Pordy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATING HIGH CARDIOVASCULAR RISK PATIENTS WITH HYPERCHOLESTEROLEMIA
    Publication number: 20200255544
    Abstract: The present invention provides methods for treating hypercholesterolemia. The methods of the present invention comprise administering to a high cardiovascular risk patient a pharmaceutical composition comprising a PCSK9 inhibitor. In certain embodiments, the PCSK9 inhibitor is an anti-PCSK9 antibody such as the exemplary antibody referred to herein as mAb316P. The methods of the present invention are useful for treating high cardiovascular risk patients with hypercholesterolemia and established CHD or CHD risk equivalents that are not adequately controlled by maximum tolerated dose statin therapy.
    Type: Application
    Filed: October 24, 2019
    Publication date: August 13, 2020
    Inventors: Corinne Hanotin, Laurence Bessac, Umesh Chaudhari, Robert Pordy, Daniel A. Schwemmer Gipe
  • METHODS FOR TREATING HIGH CARDIOVASCULAR RISK PATIENTS WITH HYPERCHOLESTEROLEMIA
    Publication number: 20160137746
    Abstract: The present invention provides methods for treating hypercholesterolemia. The methods of the present invention comprise administering to a high cardiovascular risk patient a pharmaceutical composition comprising a PCSK9 inhibitor. In certain embodiments, the PCSK9 inhibitor is an anti-PCSK9 antibody such as the exemplary antibody referred to herein as mAb316P. The methods of the present invention are useful for treating high cardiovascular risk patients with hypercholesterolemia and established CHD or CHD risk equivalents that are not adequately controlled by maximum tolerated dose statin therapy.
    Type: Application
    Filed: July 16, 2015
    Publication date: May 19, 2016
    Inventors: Corinne Hanotin, Laurence Bessac, Umesh Chaudhari, Robert Pordy, Daniel A. Schwemmer Gipe